Product image of Mupirocina Infectopharm (Mupirocin) supplied by GNH India

Mupirocina Infectopharm

Active Ingredient:
Mupirocin
Origin:
EU

Mupirocina Infectopharm (Mupirocin)

Mupirocin, the active ingredient in Mupirocina Infectopharm, is a monoxycarbolic acid antibiotic presented as a nasal ointment for nasal use. It treats bacterial colonisation of the nasal passages, particularly Staphylococcus aureus, in both adults and children.

GNH India supplies Mupirocina Infectopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for bulk and packaged forms across multiple regions, including Europe, Asia and the Americas globally.

Manufacturer / TM Owner

Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mupirocin is a topical antibacterial agent used to eradicate nasal colonisation of Staphylococcus aureus.

  • Nasal carriage of Staphylococcus aureus: eliminates bacterial colonisation and reduces risk of subsequent infection.
  • Pre‑surgical decolonisation: prepares patients for surgery by removing nasal MRSA, lowering postoperative infection rates.
  • Prevention of recurrent skin infections: reduces recurrence in carriers by clearing nasal reservoirs.

How It Works

  • Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for incorporation of isoleucine into nascent proteins. By binding to the active site of the synthetase, it blocks the formation of isoleucyl‑tRNA, halting protein synthesis and leading to bacterial growth arrest and cell death. The action is bactericidal against most gram‑positive organisms, including methicillin‑resistant Staphylococcus aureus. The limited systemic absorption after nasal application confines its activity to the local mucosa.

Side Effects

Mupirocin nasal ointment may cause local and, rarely, systemic adverse reactions.

Common Side Effects

  • Nasal irritation: mild burning or stinging at the application site.
  • Itching: localized pruritus in the nasal mucosa.
  • Dryness: sensation of dryness inside the nose.

Serious or Rare Side Effects

  • Allergic contact dermatitis: redness, swelling, and rash requiring medical attention.
  • Anaphylaxis: severe systemic allergic reaction with difficulty breathing or hypotension.
  • Stevens‑Johnson syndrome: severe skin reaction that may involve mucous membranes.

Precautions & Warnings

When using Mupirocina Infectopharm, consider the following precautions.

  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: limited data; weigh risk versus benefit.
  • Age restrictions: not recommended for infants under 2 months without medical supervision.
  • Concomitant antibiotics: may reduce effectiveness if systemic antibiotics target the same organisms.
  • Resistance: avoid prolonged use to prevent bacterial resistance development.
  • Store at below 25°C: keep in original container, protect from moisture and light.

Avoid Interactions

Mupirocina Infectopharm may interact with other medicines.

Major Interactions (Avoid)

  • Systemic antibiotics with overlapping spectrum (e.g., oral clindamycin): may diminish mupirocin’s local efficacy.
  • Topical nasal decongestants or steroids: increase risk of irritation and reduced absorption.

Moderate Interactions (Monitor Closely)

  • Other topical antibiotics (e.g., bacitracin): potential additive irritation.
  • Antifungal nasal preparations: may alter local flora.
  • Immunosuppressive therapy: heightened risk of infection despite treatment.

Frequently Asked Questions

Mupirocina Infectopharm is a nasal ointment containing mupirocin that is used to eradicate Staphylococcus aureus colonisation in the nasal passages. It is commonly prescribed for carriers of methicillin‑resistant Staphylococcus aureus (MRSA) to reduce the risk of infection and to prepare patients for surgical procedures.

Mupirocin blocks bacterial isoleucyl‑tRNA synthetase, an enzyme required for protein synthesis. By preventing the formation of isoleucyl‑tRNA, the drug halts bacterial protein production, leading to bactericidal activity against gram‑positive organisms, especially Staphylococcus aureus.

The dosage and duration are determined by the prescribing clinician based on the patient’s condition, age, and response to therapy. Typical regimens involve applying a thin layer of the ointment inside each nostril once or twice daily for a prescribed number of days.

Safety data for mupirocin during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mupirocin is considered the reference standard for nasal MRSA decolonisation because of its potent activity against Staphylococcus aureus and low systemic absorption. Alternative agents, such as povidone‑iodine or chlorhexidine, have broader antimicrobial spectra but may cause more irritation and lack the same level of clinical evidence for MRSA eradication.

Store the ointment at temperatures below 25 °C, in its original container, protected from moisture and direct light. Keep the product out of reach of children and avoid freezing. Do not use the product after the expiry date printed on the packaging.

Apply a thin layer of the ointment to the interior of each nostril using a clean fingertip or applicator, as directed by the prescriber. The medication is intended for local use only; do not ingest or apply to other body sites unless instructed.

Serious adverse reactions, although rare, include allergic contact dermatitis, anaphylaxis, and severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if signs of a severe allergic reaction or extensive skin involvement occur.

Individuals with a known hypersensitivity to mupirocin or any component of the formulation should avoid using the product. It is also not recommended for infants younger than two months without explicit medical supervision, and caution is advised in pregnant or breastfeeding women.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mupirocin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT